Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Metformin or Sulfonylureas and Metformin
Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
This study is designed to compare the effects of twice-daily exenatide plus oral antidiabetic
(OAD) agents and twice-daily placebo plus OAD with respect to glycemic control.